Vir Biotechnology Announces Strategic Steps to Reduce Operating Expenses and Focus Investment on Areas with Highest Potential for Value Creation

SAN FRANCISCO–(BUSINESS WIRE)—- $VIR–Vir Biotechnology makes strategic changes to focus capital allocation on programs with the highest potential for patient impact and value creation.
Click here to view original post